Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets

NCT01975220 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Empagliflozin/Metformin XR, FDC
DRUG: Empagliflozin/Metformin XR FDC
DRUG: 25 mg Empagliflozin/1000 mg Metformin XR, FDC
DRUG: 1 tablet Empagliflozin/2 tablets Metformin XR
DRUG: 1 tablet Empagliflozin/3 tablets Metformin XR
DRUG: 1 tablet Empagliflozin/2 tablets Metformin XR

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]